Relationship between homocysteine and superoxide dismutase in homocystinuria: Possible relevance to cardiovascular risk

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 5, 2000, Pages 1199-1202

  Wilcken, David E L ^a   Wang, Xing Li ^a   Adachi, Tetsuo ^b   Hara, Hirokazu ^b   Duarte, Natalia ^a   Green, Kathryn ^c   Wilcken, Bridget ^c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Cystathionine synthase deficiency; Homocysteine; Oxidative stress; Superoxide dismutase; Vascular disease

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE; METHIONINE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; AMINO ACID ANALYSIS; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOCYSTINURIA; HUMAN; INFANT; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0343569885     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.5.1199     Document Type: Article

References (22)

1. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest. 1976;57: 1079-1082.
2. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31-62.
3. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354:407-413.
4. Mudd SH, Skovby F, Levy HL, Pettigrew KR, Wilcken B, Pyeritz R, Andria G, Boers GH, Bromberg IL. Cerone R, et al. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet. 1985;37:1-31.
5. Wilcken DEL, Wilcken B. The natural history of vascular disease in homocystinuria and effects of treatment. J Inherit Metab Dis. 1997;20: 295-300.
6. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274: 1049-1057.
7. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230-236.
8. Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol. 1993;22:854-858.
9. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilatation in humans. Circulation. 1997;95:1119-1121.
10. Tsai J-C, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee ME. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91: 6369-6373.
11. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 1996;98:5-7.
12. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 1996;271:C1424-C1437.
13. Squadrito GL, Pryor WA. The formation of peroxynitrite in vivo from nitric oxide and superoxide. Chem Biol Interact. 1995;96:203-206.
14. Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular Superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15: 2031-2036.
15. Wang XL, Adachi T, Sim AS, Wilcken DEL. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:1915-1921.
16. Frantzen F, Faaren AL, Alfhein I, Nordhei AK. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem. 1998;44:311-316.
17. Adachi T, Ohta H, Yamada H, Futenma A, Kato K, Hirano K. Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta. 1992;212:89-102.
18. Sandström J, Nilsson P, Karlsson K, Marklund SL. Ten-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem. 1994;269: 19163-19166.
19. Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet. 1998;351:36-37.
20. Verhaar CM, Wever RMF, Kastelein JJP, van Dam T, Koomans HA, Rabelink TJ. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 1998;97:237-241.
21. Homocysteine Lowering Triallist's Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ. 1998;316:894-898.
22. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci. 1999;96:235-239.